Know Labs (NYSE:KNW) today announced results from a new study that further demonstrate the accuracy of its Bio-RFID sensor technology.
Last month, the company unveiled the prototype for its proprietary non-invasive sensor technology. Its proprietary Bio-RFID technology uses spectroscopy to direct electromagnetic energy through a substance or material. Through this, it can capture a unique molecular signature. The Know Labs technology integrates into wearable, mobile or bench-top form factors.
Seattle-based Know Labs’ study showed that continued algorithm refinement and more high-quality data improved the sensor’s accuracy.
Get the full story at our sister site, Drug Delivery Business News.